Complete report $34,500. DataPack (test volumes, sales forecasts, supplier shares) $19,500.
This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.
The report explores future marketing and technological trends in the US, Europe and Japan; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated molecular and immunohematology analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.
Blood Group Genotyping
PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR,
Real Time PCR, Sanger DNA Sequencing, Pyrosequencing
BeadChip Array, BloodChip, Genome Lab SNP Stream,
Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS,
Blood Typing and Grouping Tests
ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin,
Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s),
Antiglobulin (Direct, C3 + IgG, IgG, C3),
Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).
Infectious Disease Screening Tests
AIDS (HIV NAT, HIV-1/2), Cytomegalovirus,
Hepatitis (HAV NAT, HBV NAT, HBs Ag,
Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II,
Parvovirus B19 NAT, Syphilis, West Nile Virus NAT.
Sales and Market Share Analysis
Sales and market share estimates for leading
suppliers of blood typing, grouping and infectious disease
screening tests by country and individual product.
France, Germany, Italy, Japan, Spain, UK, USA
Strategic assessments of major suppliers and
emerging market entrants, including their sales, M&A,
product portfolios, marketing tactics, and new products in R&D.
Market Segmentation Analysis
- Comprehensive market segmentation
analysis, including review of the market
dynamics, trends, structure, size, growth,
and key suppliers, by country.
- Test volume and sales forecasts for over 40 blood typing,
grouping and infectious disease screening tests,
including NAT, by country and market segment:
- Blood Centers
- Plasma Fractionation Facilities
- Commercial/Private Laboratories
- Military Blood Banks
Current and Emerging Products
- Analysis of current and emerging molecular blood typing,
grouping and infectious disease NAT screening assays.
- Review of automated and semi-automated
molecular and immunohematology analyzers.
- Assessment of current and emerging
technologies, and their potential applications
for the blood banking market.
- Comprehensive lists of companies developing
or marketing new technologies and products, by test.
Worldwide Market Overview
- Estimates of facilities performing blood banking tests, by country.
- Test volume and sales projections by country.
- New product development opportunities
for molecular blood typing, grouping and
infectious disease NAT assays and instrumentation
with significant market appeal.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
Contains 775 pages and 227 tables
SIMILAR MARKET STUDIES
This unique report from VPGMarketResearch provides Spain sales and market share estimates for major suppliers of molecular diagnostic products. The report also presents strategic assessments of major suppliers and emerging market entrants, including their product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies. Competitive Assessments ...
May 2016 | $0 | View Details >>
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country ...
January 2014 | $2800 | View Details >>
2014-2018 U.K. Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostic Testing Markets: Country Forecasts, Emerging Technologies, Competitive Strategies This new study from Venture Planning Group contains 408 pages, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products in testing for genetic diseases, cancer, as well as forensic and paternity/HLA typing applications during the next five years.
November 2014 | $1200 | View Details >>
2015-2019 UK Sexually-Transmitted Disease (STD) Diagnostics Market: Chancroid, Chlamydia, Gonorrhea, Herpes, HPV, Syphilis-Competitive Strategies, Supplier Shares, Country Segment Forecasts, Innovative Technologies, Instrumentation Review
About This ReportThis report presents a detailed analysis of the UK STD market, including sales forecasts and supplier shares for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs. In addition to ...
July 2015 | $1250 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research